EWM
LKFT

Empirical Wealth Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Empirical Wealth Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,469
Closed -$605K – 930
2025
Q3 		$605K Buy
17,469
+8,157
+88% +$261K 0.01% 424
2025
Q2 		$261K Buy
+9,312
New +$250K 0.01% 570

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Empirical Wealth Management's LKFT Position: Q4 2025 in Review

Empirical Wealth Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 17,469 shares — an estimated $605K sold.

Empirical Wealth Management first reported a position in LKFT in Q2 2025 and held it in 2 quarters. The position peaked at $605K in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

  • Empirical Wealth Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Empirical Wealth Management sold 17,469 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $605K.
  • Empirical Wealth Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2025 and held it in 2 quarters.
  • Empirical Wealth Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $605K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Empirical Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.